Clicky

Medtronic PLC(2M6)

Description: Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.


Keywords: Artificial Intelligence Pain Surgery Medical Device Neuroscience Catheter Pain Management Implant Prosthetics Interventional Radiology Cardiac Electrophysiology Healthcare System Biomedical Engineering Angioplasty Repair Products Hernia Percutaneous Cardiac Resynchronization Therapy Medtronic Artificial Cardiac Pacemaker Continuous Glucose Monitoring Systems Biotronik Electrosurgery Products Airway Management Products Cardiac Resynchronization Therapy Devices Insertable Cardiac Monitor Systems Biologic Solutions Cardiac Ablation Products Device Based Medical Therapies Diabetes Operating Unit Energy Surgical Instruments Gynecology Products Hernia Mechanical Devices Interventional Products Patient Centered Software Percutaneous Coronary Intervention Products Robotic Assisted Surgery Products Transcatheter Pulmonary Valves

Home Page: www.medtronic.com

Building Two
Galway,
Ireland
Phone: 353 1 438 1700


Officers

Name Title
Mr. Geoffrey Straub Martha Chairman of the Board & CEO
Mr. Sean M. Salmon Executive VP & President of Cardiovascular Portfolio
Mr. Brett A. Wall Executive VP & President of Neuroscience Portfolio
Mr. Gregory L. Smith Executive Vice President of Global Operations & Supply Chain
Gary Corona Senior Vice President of Global Financial Planning and Analysis & Interim CFO
Mr. Mark Ploof Senior Vice President of Global Operations and Business Services
Ms. Jennifer M. Kirk Senior VP, Global Controller & Chief Accounting Officer
Dr. Kenneth E. Washington Ph.D. Senior VP and Chief Technology & Innovation Officer
Dr. Laura Mauri M.D., M.Sc. Senior VP and Chief Scientific & Medical Officer
Mr. Ryan Weispfenning VP & Head of Investor Relations

Exchange: XETRA

Country: DE : Germany

Currency: Euro (€)

Forward PE: 15.4799
Trailing PE: 25.8091
Price-to-Book MRQ: 2.2322
Price-to-Sales TTM: 3.1506
IPO Date:
Fiscal Year End: April
Full Time Employees: 95000
Back to stocks